Practice Areas - Equity Capital Markets Law Firms and Lawyers
Deal Date: | 09-03-2012 | Practice Area: | Equity Capital Markets |
Deal Title: | VIVUS, Inc Follow-on Public Stock Offering | Industry: | Pharmaceuticals & Biotechnology |
Description: |
Hogan Lovells represented biopharmaceutical company VIVUS, Inc. (Nasdaq: VVUS) on its US$200 million follow-on public stock offering, which closed on 6 March.
On 29 February, VIVUS announced the pricing of an underwritten public offering of 9,000,000 shares of its common stock (plus an over-allotment option to purchase 1,350,000) at a price to the public of US$22.50 per share. The gross proceeds from the sale of the shares, before underwriting discounts and commissions and other offering expenses, are expected to be approximately US$202.5 million.
The team of Hogan Lovells lawyers advising VIVUS on the offering included Silicon Valley partners Jon Layman and Laura Berezin and Washington, D.C. associate Jaime Chase.
|
||
Financial Center: | Silicon Valley | Value: | 100.01-500.00 |
Advised Party: | Issuer | Law Firm | Hogan Lovells |
Issuer Jurisdiction - | United States | Listing Jurisdiction - | United States |
Classification: |
Secondary Offerings and Placings NASDAQ: |
Lawyer | Laura Berezin |